<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Anesthesiol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Anesthesiol</journal-id><journal-title-group><journal-title>BMC Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">1471-2253</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28283018</article-id><article-id pub-id-type="pmc">5346230</article-id><article-id pub-id-type="publisher-id">332</article-id><article-id pub-id-type="doi">10.1186/s12871-017-0332-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Tramadol vs dexmedetomidine for emergence agitation control in pediatric patients undergoing adenotonsillectomy with sevoflurane anesthesia: prospective randomized controlled clinical study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2624-0259</contrib-id><name><surname>Bedirli</surname><given-names>Nurdan</given-names></name><address><phone>+903122025334</phone><email>nurbedirli@yahoo.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Ak&#x000e7;abay</surname><given-names>Mehmet</given-names></name><address><email>akcabay@gazi.edu.tr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Emik</surname><given-names>Ulku</given-names></name><address><email>emik@gazi.edu.tr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2169 7132</institution-id><institution-id institution-id-type="GRID">grid.25769.3f</institution-id><institution>Department of Anesthesiology, </institution><institution>Gazi University Medical School, </institution></institution-wrap>Kumeevler cad., Siyasal sit., No:44, 06810 Cayyolu, Ankara Turkey </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>17</volume><elocation-id>41</elocation-id><history><date date-type="received"><day>28</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>This study was designed to compare the efficacy of an intraoperative single dose administration of tramadol and dexmedetomidine on hemodynamics and postoperative recovery profile including pain, sedation, emerge reactions in pediatric patients undergoing adenotonsillectomy with sevoflurane anesthesia.</p></sec><sec><title>Methods</title><p>Seventy-seven patient, aged 2&#x02013;12, undergoing adenotonsillectomy with sevoflurane anesthesia was enrolled in this study. Patients were randomly assigned to receive either intravenous 2&#x000a0;mg/kg tramadol (Group T; <italic>n</italic>&#x02009;=&#x02009;39) or 1&#x000a0;&#x003bc;g/kg dexmedetomidine (Group D; <italic>n</italic>&#x02009;=&#x02009;38) after intubation. Heart rates (HR), mean arterial pressure (MAP) were recorded before induction, at induction and every 5&#x000a0;min after induction. Observational pain scores (OPS), pediatric anesthesia emergence delirium (PAED) scores, percentage of patients with OPS&#x02009;&#x02265;&#x02009;4 or PAED scale items 4 or 5 with an intensity of 3 or 4, and Ramsay sedation scores (RSS) were recorded on arrival to the postoperative care unit (PACU) and at 5, 10, 15, 30, 45, 60&#x000a0;min. Extubation time and time to reach Alderete score&#x02009;&#x0003e;&#x02009;9 were recorded.</p></sec><sec><title>Results</title><p>Dexmedetomidine significantly decreased the HR and MAP 10 and 15&#x000a0;min after induction; increased the RSS 15, 30 and 45&#x000a0;min after arrival to PACU. OPS and PAED scores and percentage of patients with OPS&#x02009;&#x02265;&#x02009;4 or PAED scale items 4 or 5 with an intensity of 3 or 4 in both groups did not show any significant difference. Extubation time and time to have Alderete score&#x02009;&#x0003e;&#x02009;9 was significantly longer in Group D.</p></sec><sec><title>Conclusion</title><p>Both tramadol and dexmedetomidine were effective for controlling pain and emergence agitation. When compared with tramadol intraoperative hypotension, bradycardia and prolonged sedation were problems related with dexmedetomidine administration.</p></sec><sec><title>Trial registration</title><p>Retrospectively registered, registration number: <ext-link ext-link-type="uri" xlink:href="http://www.isrctn.com/ISRCTN89326952?q=&#x00026;filters=conditionCategory:Signs%20and%20Symptoms,recruitmentCountry:Turkey&#x00026;sort=relevance&#x00026;offset=1&#x00026;totalResults=3&#x00026;page=1&#x00026;pageSize=10&#x00026;searchType=basic-search">ISRCTN89326952</ext-link> registration date: 14.07.2016</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Tramadol</kwd><kwd>Dexmedetomidine</kwd><kwd>Pediatric recovery</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Adenotonsillectomy in childhood is a common ambulatory surgical procedure requiring general anesthesia, effective pain control, and fast tract recovery [<xref ref-type="bibr" rid="CR1">1</xref>]. Postoperative period following adenotonsillectomy is often challenging and maintaining effective pain control is important to decrease the incidence of the emergence agitation, dehydration, and hemorrhage from healing surgical wounds [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. The choice of analgesic agents influences the occurrence of complications such as postoperative nausea and vomiting (PONV), emergence agitation, and cardiorespiratory complications [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>Sevoflurane is a preferred inhalational anesthetic for both general anesthesia induction and maintenance in children because it is characterized with rapid onset and offset, less irritation to the airway [<xref ref-type="bibr" rid="CR5">5</xref>]. However, sevoflurane is associated with a high incidence of emergence agitation which may delay patient discharge from the hospital [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>].</p><p>Emergence agitation is a frequent complication in children undergoing otorhinolaryngologic surgery under general anesthesia, with an estimated incidence of 18&#x02013;80% [<xref ref-type="bibr" rid="CR8">8</xref>]. Emergence agitation has the risks of self-injury, delayed discharge, extra nursing care, family dissatisfaction, and increased cost [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p>Dexmedetomidine, a highly selective &#x003b1;-2 receptor agonist and commonly used in adult anesthesia and intensive care [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. Studies evaluating the intraoperative Dexmedetomidine showed that opioid consumption and pain intensity incidence reduced [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Studies in pediatric patients evidenced that Dexmedetomidine is also beneficial in the pediatric perioperative period, it&#x02019;s anxiolytic, sedative, and analgesic properties is beneficial for emergence agitation control [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Bradycardia and decrease in blood pressure are common unwanted sympatholytic side effects associated with dexmedetomidine administration and even sinus arrest has been reported with dexmedetomidine [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. These hemodynamic side-effects of dexmedetomidine limit its application at anesthesia practice of pediatric patients [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p>Tramadol, a derivate of aminocyclohexanol, has similar analgesic action compared with the opioids and has potential advantages including a long duration of action, rapid recovery, and limited respiratory depressant effects [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Tramadol may offer a choice for treatment of pain after tonsillectomy [<xref ref-type="bibr" rid="CR18">18</xref>]. Tramadol has been shown to reduce postoperative analgesic requirements when given intraoperatively [<xref ref-type="bibr" rid="CR19">19</xref>]. Although the overall evidence regarding tramadol for postoperative pain in children is currently low, studies demonstrated that intraoperative administration of tramadol provided effective postoperative analgesia with fast tract recovery [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p>This study was designed to evaluate the efficiency of dexmedetomidine and tramadol for controlling postoperative pain, emergence agitation, and intraoperative hemodynamic side effects in patients undergoing ambulatory adenotonsillectomy.</p></sec><sec id="Sec2"><title>Methods</title><p>The study was approved by local ethics committee, written informed consent from the parents/guardians was obtained, and the study performed in accordance with the Declaration of Helsinki. Eighty patients, ASA physical status I&#x02013;II aged 2&#x02013;12, undergoing adenotonsillectomy were enrolled in this prospective, randomized, double blinded study. Patients with the history of developmental delay, cardiac disorder, psychological disorder, epilepsy, and allergy to study medications were excluded from the study. Patients did not have any premedication.</p><p>Standard monitoring included electrocardiogram, noninvasive blood pressure, pulse oximetry, and inspiratory and expiratory gas concentrations. Anesthesia was induced with 8% inspired sevoflurane and 60% nitrous oxide in oxygen by facemask. After induction an intravenous catheter was inserted and 1&#x000a0;&#x003bc;g/kg intravenous (iv) fentanyl was given as bolus and rocuronium 0.6&#x000a0;mg/kg was administered to facilitate tracheal intubation.</p><p>Patients were assigned to one of two groups according to a computer generated random numbers table. After intubation patients in dexmedetomidine group (Group D, <italic>n</italic>&#x02009;=&#x02009;38) received 1&#x000a0;&#x003bc;g/kg dexmedetomidine and the patients in tramadol group (Group T, <italic>n</italic>&#x02009;=&#x02009;39) received 2&#x000a0;mg/kg tramadol. The study drugs were diluted in saline as follows: dexmedetomidine 20&#x000a0;&#x003bc;g/ml (2&#x000a0;ml of dexmedetomidine and 8&#x000a0;ml of saline) and tramadol 20&#x000a0;mg/ml (4&#x000a0;ml of tramadol and 6&#x000a0;ml of saline) and administered as a single iv dose over a 10&#x000a0;min&#x02019; period. The anesthetist who administered the study drugs was blinded to the patient group and excluded from the perioperative assessment of the patient. Heart rate (HR), mean arterial pressure (MAP), peripheral oxygen saturation (SpO<sub>2</sub>), and minimum alveolar concentration (MAC) were recorded before induction (baseline), at induction and every 5&#x000a0;min after induction during the procedure.</p><p>For anesthesia maintenance patients received 2% sevoflurane in 60% N<sub>2</sub>O and 40% oxygen with controlled ventilation to maintain normocapnia. In both groups 25% increase in HR and MAP with respect to the value before anesthesia induction and sustained for 5&#x000a0;min was considered as tachycardia and hypertension respectively and treated with 0.5&#x000a0;&#x003bc;g/kg fentanyl. Likewise, 25% decrease in HR and MAP is defined as bradycardia and hypotension respectively. Atropine 0.01&#x000a0;mg/kg intravenously for bradycardia and 10&#x000a0;ml/kg normal saline solution for hypotension was administered to the patients. Intraoperative dexamethasone 0.5&#x000a0;mg/kg (maximum 10&#x000a0;mg), ondansetron 0.1&#x000a0;mg/kg and antibiotics were administered to all patients according to institutional practice for tonsillectomy. Normal saline solution was administered for fluid management to all the patients.</p><p>Tonsillectomies were performed by two surgeons using extracapsular electro-cautery dissection technique. When hemostasis was achieved, anesthetic gases were discontinued and neuromuscular blockade was reversed with neostigmine 0.05&#x000a0;mg/kg and atropine 0.02&#x000a0;mg/kg iv. The trachea was extubated when patients had eye opening, purposeful movement, or response to command and the patients were transferred to post anesthesia care unit (PACU). The duration between the termination of anesthetic gasses and the extubation was defined as &#x02018;extubation time&#x02019;.</p><p>In PACU the intensity of pain was assessed by using a modified Hannallah pain score [<xref ref-type="bibr" rid="CR21">21</xref>] &#x02013; an observational pain score (OPS). Moreover, pediatric anesthesia emergence delirium (PAED) scale [<xref ref-type="bibr" rid="CR22">22</xref>], Ramsay sedation score (RSS) [<xref ref-type="bibr" rid="CR23">23</xref>], HR, MAP, SpO<sub>2</sub> were measured and recorded on arrival to PACU and 5, 10, 15, 30, 45, 60&#x000a0;min after arrival to PACU. Besides, any adverse effects such as vomiting, airway obstruction, laryngospasm or bronchospasm were recorded. All these measurements and recordings were done by the same doctor who was blind to the group of the patient.</p><p>The number of patients who presented with OPS&#x02009;&#x02265;&#x02009;4 or PAED scale items 4 <italic>&#x02018;the child is restless&#x02019;</italic> or 5 <italic>&#x02018;the child is inconsolable&#x02019;</italic> with an intensity of 3 (very much) or 4 (extremely) were recorded and 0.05&#x000a0;mg/kg morphine as rescue analgesic were administered to these patients. Patients who had an Alderete score&#x02009;&#x0003e;&#x02009;9 discharged from PACU to surgical ward. The duration between acceptance to PACU and discharge from PACU to surgical ward was defined as &#x02018;time to reach Alderete score&#x02009;&#x0003e;&#x02009;9&#x02019;.</p><p>Duration of surgery and anesthesia, extubation time, need for morphine, the incidence of vomiting during the 60&#x000a0;min period, and time to reach Alderete score&#x02009;&#x0003e;&#x02009;9 was recorded.</p><sec id="Sec3"><title>Statistical analyses</title><p>Statistical analyses were performed using statistical package (SPSS 11.0 for windows, SPSS Inc, Chicago). Data are presented as mean and standard deviation, median and range as appropriate. The primary end point of the study was the need for rescue morphine of the patients in PACU. The secondary outcomes were the degree of sedation of the patients in PACU, incidence of postoperative vomiting, and the time to reach Alderete score of &#x0003e;9. The number of patients in each group was determined by a power calculation based on the results of Qlutoye AO et al. [<xref ref-type="bibr" rid="CR2">2</xref>]. It was calculated that 35 patients needed per group assuming an &#x003b1; risk of 0.05 and a &#x003b2; risk of 0.10 and mean difference of 50%. To account for exclusion of some patients, we enrolled 40 patients in each group. Demographic data compared using the Student&#x02019;s <italic>t-test</italic>. MAP, HR, SpO<sub>2</sub>, MAC data were analyzed using two-way repeated measures analysis of variance (ANOVA). OPS, PAED, and PAED score were expressed as median values and compared with Mann-Whitney <italic>U</italic> test. Statistical significance was accepted when the <italic>P</italic> value was less than 0.05.</p></sec></sec><sec id="Sec4"><title>Results</title><p>Eighty patients enrolled randomization and seventy-seven were included in the analysis. Three patients were excluded because the parents did not agree to participate (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The two groups were comparable with respect to age, weight, gender, anesthesia time, and surgical time (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The difference with regard to MAC values of sevoflurane in Group T and Group D was not significant (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, <italic>P&#x02009;=</italic>&#x02009;0.12). Extubation time and time to have Alderete score&#x02009;&#x0003e;&#x02009;9 was significantly longer in Group D (6.8&#x02009;&#x000b1;&#x02009;1.7&#x000a0;min and 37.6&#x02009;&#x000b1;&#x02009;5.4&#x000a0;min) when compared to Group T (3.2&#x02009;&#x000b1;&#x02009;0.6&#x000a0;min and 15.2&#x02009;&#x000b1;&#x02009;4.7&#x000a0;min) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>
<italic>P&#x02009;=</italic>&#x02009;0.0012 and <italic>P&#x02009;=</italic>&#x02009;0.0013, respectively). The mean dosage of rescue morphine requirement in PACU was 0.07&#x02009;&#x000b1;&#x02009;0.01&#x000a0;mg/kg in Group T and 0.06&#x02009;&#x000b1;&#x02009;0.02&#x000a0;mg/kg in Group D and the difference was not significant (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, <italic>P&#x02009;=</italic>&#x02009;0.16). In addition, there were no significant difference in the incidence of patients requiring rescue morphine between the two groups (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, <italic>P&#x02009;=</italic>&#x02009;0.17). Comparison of the incidence of vomiting between the groups did not show any significant difference during postoperative period (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, <italic>P&#x02009;=</italic>&#x02009;0.31). None of the patients exhibited with signs of laryngospasm or bronchospasm in PACU.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart of the study</p></caption><graphic xlink:href="12871_2017_332_Fig1_HTML" id="MO1"/></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic and Clinical Data</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Group T (<italic>n</italic>&#x02009;=&#x02009;39)</th><th>Group D (<italic>n</italic>&#x02009;=&#x02009;38)</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td>Age (years)</td><td>8.4&#x02009;&#x000b1;&#x02009;2.1</td><td>6.7&#x02009;&#x000b1;&#x02009;3.1</td><td char="." align="char">0.06</td></tr><tr><td>Weight (kg)</td><td>28.3&#x02009;&#x000b1;&#x02009;3.7</td><td>27.1&#x02009;&#x000b1;&#x02009;2.7</td><td char="." align="char">0.16</td></tr><tr><td>Gender (M/F)</td><td>27/13</td><td>21/19</td><td char="." align="char">0.26</td></tr><tr><td>Duration of surgery (minutes)</td><td>38.7&#x02009;&#x000b1;&#x02009;7.4</td><td>40.2&#x02009;&#x000b1;&#x02009;5.2</td><td char="." align="char">0.31</td></tr><tr><td>Duration of anesthesia (minutes)</td><td>40.3&#x02009;&#x000b1;&#x02009;1.3</td><td>41.9&#x02009;&#x000b1;&#x02009;1.2</td><td char="." align="char">0.36</td></tr><tr><td>MAC values</td><td>1&#x02009;&#x000b1;&#x02009;0.2</td><td>0.9&#x02009;&#x000b1;&#x02009;0.2</td><td char="." align="char">0.12</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as number of patients and mean&#x02009;&#x000b1;&#x02009;SD </p></table-wrap-foot></table-wrap>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Data in PACU</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Group T (<italic>n</italic>&#x02009;=&#x02009;39)</th><th>Group D (<italic>n</italic>&#x02009;=&#x02009;38)</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td colspan="4">Rescue morphine</td></tr><tr><td>&#x02009;&#x02009;&#x02022;Mean dosage (mg/kg)</td><td>0.07&#x02009;&#x000b1;&#x02009;0.01</td><td>0.06&#x02009;&#x000b1;&#x02009;0.02</td><td>0.16</td></tr><tr><td>&#x02009;&#x02009;&#x02022;Incidence (number of patients)</td><td>19</td><td>17</td><td>0.17</td></tr><tr><td>Incidence of vomiting (number of patients)</td><td>6</td><td>4</td><td>0.31</td></tr><tr><td>Time to reach Alderete Score&#x02009;&#x0003e;&#x02009;9 (minutes)</td><td>15.2&#x02009;&#x000b1;&#x02009;4.7</td><td>37.6&#x02009;&#x000b1;&#x02009;5.4</td><td>0.0013<sup>*</sup>
</td></tr><tr><td>Extubation time</td><td>3.2&#x02009;&#x000b1;&#x02009;0.6</td><td>6.8&#x02009;&#x000b1;&#x02009;1.7</td><td>0.0012<sup>*</sup>
</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as number of patients and mean&#x02009;&#x000b1;&#x02009;SD; <sup>*</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, Group T was compared to Group D</p></table-wrap-foot></table-wrap>
</p><p>Intraoperative HR and MAP are presented in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. When compared to tramadol administration dexmedetomidine decreased the HR and MAP values all through the procedure. In Group D, HR significantly decreased 10 and 15&#x000a0;min after induction (<italic>P&#x02009;=</italic>&#x02009;0.002 and <italic>P&#x02009;=</italic>&#x02009;0.001, respectively) and MAP also decreased significantly at the same time points (<italic>P&#x02009;=</italic>&#x02009;0.001 and <italic>P&#x02009;=</italic>&#x02009;0.001, respectively). None of the patients required rescue fentanyl for tachycardia or hypertension during the procedure. Postoperative HR and MAP did not show any significant differences between groups (<italic>P&#x02009;&#x0003e;</italic>&#x02009;0.05). SpO<sub>2</sub> values were ranged between 97 and 100% in both groups throughout the study and there were no significant differences between the groups (<italic>P&#x02009;=</italic>&#x02009;0.22).<fig id="Fig2"><label>Fig. 2</label><caption><p>Intraoperative Mean Arterial Pressure (MAP) and Heart Rate (HR) values of the groups. <sup>*</sup>
<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, when Group T is compared to Group D</p></caption><graphic xlink:href="12871_2017_332_Fig2_HTML" id="MO2"/></fig>
</p><p>OPS and PAED data are presented in Tables&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. Both OPS and PAED scores and the number of patients with OPS&#x02009;&#x02265;&#x02009;4 and PAED items&#x02009;&#x02265;&#x02009;4 with an intensity of 3 or 4 in both groups did not showed any significant difference (<italic>P&#x02009;&#x0003e;</italic>&#x02009;0.05). Patients in Group D had significantly higher sedation scores 15, 30 and 45&#x000a0;min after arriving to PACU compared to patients in the Group T (<italic>P&#x02009;=</italic>&#x02009;0.003, <italic>P&#x02009;=</italic>&#x02009;0.002, <italic>P&#x02009;=</italic>&#x02009;0.002, respectively, Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Observational Pain Score (OPS) Evaluation</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th>Arrival</th><th>5&#x000a0;min</th><th>10&#x000a0;min</th><th>15&#x000a0;min</th><th>30&#x000a0;min</th><th>45&#x000a0;min</th><th>60&#x000a0;min</th></tr></thead><tbody><tr><td rowspan="3">Group T (<italic>n</italic>&#x02009;=&#x02009;39)</td><td rowspan="2">OPS score</td><td>3</td><td>3</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>(2&#x02013;5)</td><td>(1&#x02013;5)</td><td>(1&#x02013;3)</td><td>(0&#x02013;0)</td><td>(0&#x02013;0)</td><td>(0&#x02013;0)</td><td>(0&#x02013;0)</td></tr><tr><td>Number of patients OPS &#x02265;4</td><td>5</td><td>4</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td rowspan="3">Group D (<italic>n</italic>&#x02009;=&#x02009;38)</td><td rowspan="2">OPS score</td><td>5</td><td>5</td><td>4</td><td>3</td><td>1</td><td>0</td><td>0</td></tr><tr><td>(3&#x02013;8)</td><td>(3&#x02013;7)</td><td>(3&#x02013;5)</td><td>(1&#x02013;4)</td><td>(0&#x02013;2)</td><td>(0&#x02013;0)</td><td>(0&#x02013;0)</td></tr><tr><td>Number of patients OPS &#x02265;4</td><td>4</td><td>3</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as median (IQR 25&#x02013;75%) and the number of the patients</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Pediatric Anesthesia Emergence Delirium Scale (PAED) Evaluation</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th>Arrival</th><th>5&#x000a0;min</th><th>10&#x000a0;min</th><th>15&#x000a0;min</th><th>30&#x000a0;min</th><th>45&#x000a0;min</th><th>60&#x000a0;min</th></tr></thead><tbody><tr><td rowspan="3">Group T (<italic>n</italic>&#x02009;=&#x02009;39)</td><td rowspan="2">PAED score</td><td>14</td><td>11</td><td>10</td><td>6</td><td>3</td><td>2</td><td>2</td></tr><tr><td>(3&#x02013;17)</td><td>(3&#x02013;13)</td><td>(0&#x02013;11)</td><td>(0&#x02013;10)</td><td>(0&#x02013;5)</td><td>(0&#x02013;5)</td><td>(0&#x02013;5)</td></tr><tr><td>Number of patients PAED items 4 or 5 with an intensity of 3 or 4</td><td>3</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td rowspan="3">Group D (<italic>n</italic>&#x02009;=&#x02009;38)</td><td rowspan="2">PAED score</td><td>15</td><td>8</td><td>3</td><td>2</td><td>2</td><td>1</td><td>1</td></tr><tr><td>(0&#x02013;17)</td><td>(0&#x02013;15)</td><td>(0&#x02013;6)</td><td>(0&#x02013;5)</td><td>(0&#x02013;5)</td><td>(0&#x02013;5)</td><td>(0&#x02013;5)</td></tr><tr><td>Number of patients PAED items 4 or 5 with an intensity of 3 or 4</td><td>3</td><td>3</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as median (IQR 25&#x02013;75%) and number of the patients</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Ramsay sedation scores of the patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Arrival</th><th>5&#x000a0;min</th><th>10&#x000a0;min</th><th>15&#x000a0;min</th><th>30&#x000a0;min</th><th>45&#x000a0;min</th><th>60&#x000a0;min</th></tr></thead><tbody><tr><td rowspan="2">Group T (<italic>n</italic>&#x02009;=&#x02009;39)</td><td>3</td><td>3</td><td>3</td><td>2</td><td>2</td><td>2</td><td>2</td></tr><tr><td>(1&#x02013;3)</td><td>(1&#x02013;3)</td><td>(2&#x02013;3)</td><td>(2&#x02013;2)</td><td>(2&#x02013;2)</td><td>(2&#x02013;2)</td><td>(2&#x02013;2)</td></tr><tr><td rowspan="2">Group D (<italic>n</italic>&#x02009;=&#x02009;38)</td><td>4</td><td>4</td><td>4</td><td>4<sup>*</sup>
</td><td>4<sup>*</sup>
</td><td>4<sup>*</sup>
</td><td>2</td></tr><tr><td>(1&#x02013;5)</td><td>(1&#x02013;5)</td><td>(2&#x02013;5)</td><td>(2&#x02013;5)</td><td>(2&#x02013;4)</td><td>(2&#x02013;4)</td><td>(2&#x02013;2)</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as median (IQR 25&#x02013;75%). <sup>*</sup>
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05; The difference was significant when Group T was compared to Group D</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec5"><title>Discussion</title><p>In this study, dexmedetomidine or tramadol was administered intraoperatively to children scheduled for adenotonsillectomy under sevoflurane anesthesia and the two drugs were compared with regard to intraoperative hemodynamic stability, postoperative pain management, emergence agitation control, and residual sedation levels.</p><p>Pain after tonsillectomy is often intense and long lasting and post tonsillectomy analgesia requires a drug that provides analgesia without respiratory depressant effect that can be used in an ambulatory setting [<xref ref-type="bibr" rid="CR24">24</xref>]. Dexmedetomidine offers some of these desired characteristics by providing relatively fast onset of sedative properties paralleling natural sleep, with minimal respiratory depression [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. But Dexmedetomidine administration may result in hypotension, bradycardia and even asystole in both children and adults and mostly these side effects have been reported when dexmedetomidine was used as rapid bolus dosages [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. In this study, dexmedetomidine was administered only as a single bolus dosage by slow intravenous injection but still we had to manage these side effects in our patients. The main problems associated with dexmedetomidine administration in our study were intraoperative hypotension, bradycardia, prolonged extubation time, and residual sedation which caused prolonged PACU stay.</p><p>The efficacy of tramadol for the management of moderate to severe postoperative pain has been demonstrated in both inpatients and ambulatory surgery patients. Most importantly, unlike other opioids, tramadol has no clinically relevant effects on respiratory or cardiovascular parameters [<xref ref-type="bibr" rid="CR29">29</xref>]. Tramadol is shown to be effective in relieving moderate to severe pain in children [<xref ref-type="bibr" rid="CR30">30</xref>], while exhibiting less respiratory depression and sedation [<xref ref-type="bibr" rid="CR31">31</xref>]. Still, Tramadol is related with side effects and the most common side effects are nausea-vomiting, dizziness, drowsiness, and constipation [<xref ref-type="bibr" rid="CR32">32</xref>]. In the pediatric age, the reported incidence of adverse events is similar to that observed in adults and increases with chronic use [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p>Despite the lack of pediatric labeling of both dexmedetomidine and tramadol, both drugs are used worldwide to treat children. In the present study, the dosage of the dexmedetomidine and tramadol was selected based on the previous studies reported in the literature [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Olutoye OA et al. [<xref ref-type="bibr" rid="CR2">2</xref>] reported that dexmedetomidine 1&#x000a0;&#x003bc;g/kg administration to pediatric patients undergoing adenotonsillectomy had the advantages of an increased time to first analgesic and a reduced need for additional rescue analgesia doses in the PACU. Pestieau SR et al. [<xref ref-type="bibr" rid="CR34">34</xref>] reported that high-dose dexmedetomidine needed to decrease opioid requirements and provide opioid-free interval after tonsillectomy in the post anesthesia care unit. Bozkurt et al. [<xref ref-type="bibr" rid="CR33">33</xref>] reported that 2&#x000a0;mg/kg iv dosage of tramadol is the best for analgesic action with minimal side effects. Therefore, in this study we investigated dexmedetomidine 1&#x000a0;&#x003bc;g/kg and tramadol 2&#x000a0;mg/kg administered as slow intravenous injection.</p><p>Pain, sore throat, laryngeal edema and airway obstruction may occur after adenotonsillectomies and are the probable etiological factors of emergence agitation. In the present study, dexamethasone and fentanyl were administered to all patients for the prevention of laryngeal edema and pain. Fentanyl administrated at induction to all the patients and planed as intraoperative rescue analgesic but none of our patients needed intraoperative rescue analgesic and dexamethasone was the drug chosen for the prevention edema for both groups. Evidently both groups benefited from the decrease in incidence of the emergence agitation but this did not affect the comparison of the groups because all the patients in both groups received the equivalent dosage of dexamethasone and fentanyl.</p><p>There are some limitations in this study. First of all, we did not monitor the depth of anesthesia by BIS. Secondly, the broad range of our patients&#x02019; age is limiting factor because age distribution is important in evaluating the postoperative pain and recovery profiles including agitation. Moreover, if there had been a control or placebo group it would be more possible to define the effectiveness of the study drugs. But at this time, failure to provide adequate analgesia in the placebo group would cause serious ethical and clinical problems.</p><p>The analgesic action of tramadol is based on a multimodal mechanism of action that involves activation at the opioid receptor as well as inhibition of norepinephrine and serotonin reuptake in the central nervous system [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Chu YC et al. [<xref ref-type="bibr" rid="CR17">17</xref>] have demonstrated that, intraoperative tramadol caused earlier awakening from general anesthesia without prolonged sedation and earlier tracheal extubation in the immediate postoperative period. However, the administration of tramadol for postoperative analgesia also may have an adverse effect on the incidence of nausea and vomiting [<xref ref-type="bibr" rid="CR17">17</xref>]. In this study, tramadol was effective in managing pain and emergence agitation with apparent lack of prolonged sedation in the early postoperative period. Moreover, extubation times of the patients who received tramadol were shorter and vomiting incidence was similar in the two groups. This data may be the result of routine administration of ondancetron and dexamethasone besides intraoperative administration of tramadol or dexmedetomidine to our patients.</p></sec><sec id="Sec6"><title>Conclusion</title><p>In this study, we have demonstrated that in pediatric patients undergoing ambulatory adenotonsillectomy both dexmedetomidine and tramadol were effective in controlling postoperative pain and emergence agitation but in comparison to tramadol dexmedetomidine administration resulted in higher incidence of, intraoperative bradycardia, hypotension, postoperative prolonged sedation, and prolonged PACU stay.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ANOVA</term><def><p>Analysis of variance</p></def></def-item><def-item><term>HR</term><def><p>Heart rate</p></def></def-item><def-item><term>Iv</term><def><p>Intravenous</p></def></def-item><def-item><term>MAC</term><def><p>Minimum alveolar concentration</p></def></def-item><def-item><term>MAP</term><def><p>Mean arterial pressure</p></def></def-item><def-item><term>OPS</term><def><p>Observational pain score</p></def></def-item><def-item><term>PACU</term><def><p>Post anesthesia care unit</p></def></def-item><def-item><term>PAED</term><def><p>Pediatric anesthesia emergence delirium</p></def></def-item><def-item><term>RSS</term><def><p>Ramsay sedation score</p></def></def-item><def-item><term>SpO2</term><def><p>Peripheral oxygen saturation</p></def></def-item></def-list></glossary><ack><title>Acknowledgement</title><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p>None.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>The datasets supporting the conclusion of this article is available from the corresponding author on reasonable request.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>NB designed the study, supervised conduct of the study and wrote the manuscript, MA was responsible for perioperative monitoring of patients and acquisition of data, UE collected and formatted the data. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing of interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>The study was approved by Erciyes University Research Ethics Committee, Kayseri, Turkey, on 01 March 2011 with the number 2011/135, and the written informed consent was obtained from the parents/guardians of each participant.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Davidson</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>MC</given-names></name><name><surname>Quraishi</surname><given-names>H</given-names></name><name><surname>Schoenberg</surname><given-names>C</given-names></name><name><surname>Sant</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy</article-title><source>Anesth Analg</source><year>2010</year><volume>111</volume><fpage>1004</fpage><lpage>1010</lpage><pub-id pub-id-type="pmid">20705788</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olutoye</surname><given-names>OA</given-names></name><name><surname>Glover</surname><given-names>CD</given-names></name><name><surname>Diefenderfer</surname><given-names>JW</given-names></name><name><surname>Mcgilberry</surname><given-names>M</given-names></name><name><surname>Wyatt</surname><given-names>MM</given-names></name><name><surname>Larrier</surname><given-names>DR</given-names></name><etal/></person-group><article-title>The effect of intraoperative dexmedetomidine on postoperative analgesia and sedation in pediatric patients undergoing tonsillectomy and adenoidectomy</article-title><source>Anesth Analg</source><year>2010</year><volume>111</volume><fpage>490</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e3181e33429</pub-id><pub-id pub-id-type="pmid">20610555</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca Canto</surname><given-names>G</given-names></name><name><surname>Pach&#x000ea;co-Pereira</surname><given-names>C</given-names></name><name><surname>Aydinoz</surname><given-names>S</given-names></name><name><surname>Bhattacharjee</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>HL</given-names></name><name><surname>Kheirandish-Gozal</surname><given-names>L</given-names></name></person-group><article-title>Adenotonsillectomy Complications: A Meta-analysis</article-title><source>Pediatrics</source><year>2015</year><volume>136</volume><fpage>702</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1542/peds.2015-1283</pub-id><pub-id pub-id-type="pmid">26391937</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>AC</given-names></name><name><surname>Atallah</surname><given-names>AN</given-names></name><name><surname>Matos</surname><given-names>D</given-names></name><name><surname>da Silva</surname><given-names>EM</given-names></name></person-group><article-title>Intravenous versus inhalational anaesthesia for paediatric outpatient surgery</article-title><source>Cochrane Database Syst Rev</source><year>2014</year><volume>7</volume><fpage>CD009015</fpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerman</surname><given-names>J</given-names></name></person-group><article-title>Inhalation agents in pediatric anaesthesia-an update</article-title><source>Curr Opin Anaesthesiol</source><year>2007</year><volume>20</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1097/ACO.0b013e32811e16e7</pub-id><pub-id pub-id-type="pmid">17479025</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>JW</given-names></name><name><surname>Murray</surname><given-names>DJ</given-names></name><name><surname>McAllister</surname><given-names>JD</given-names></name><name><surname>Hirshberg</surname><given-names>GE</given-names></name></person-group><article-title>Emergence behaviour in children: defining the incidence of excitement and agitation following anaesthesia</article-title><source>Paediatr Anaesth</source><year>2002</year><volume>12</volume><fpage>442</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1046/j.1460-9592.2002.00868.x</pub-id><pub-id pub-id-type="pmid">12060332</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuratani</surname><given-names>N</given-names></name><name><surname>Oi</surname><given-names>Y</given-names></name></person-group><article-title>Greater incidence of emergence agitation in children after sevoflurane anesthesia as compared with halothane: a meta-analysis of randomized controlled trials</article-title><source>Anesthesiology</source><year>2008</year><volume>109</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31817f5c18</pub-id><pub-id pub-id-type="pmid">18648231</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voepel-Lewis</surname><given-names>T</given-names></name><name><surname>Malviya</surname><given-names>S</given-names></name><name><surname>Tait</surname><given-names>AR</given-names></name></person-group><article-title>A prospective cohort study of emergence agitation in the pediatric postanesthesia care unit</article-title><source>Anesth Analg</source><year>2003</year><volume>96</volume><fpage>1625</fpage><lpage>1630</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000062522.21048.61</pub-id><pub-id pub-id-type="pmid">12760985</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>Dexmedetomidine for preventing sevoflurane-related emergence agitation in children: a meta-analysis of randomized controlled trials</article-title><source>Acta Anaesthesiol Scand</source><year>2014</year><volume>58</volume><fpage>642</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1111/aas.12292</pub-id><pub-id pub-id-type="pmid">24588393</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>J</given-names></name><name><surname>Fraser</surname><given-names>GL</given-names></name><name><surname>Puntillo</surname><given-names>K</given-names></name><name><surname>Ely</surname><given-names>EW</given-names></name><name><surname>G&#x000e9;linas</surname><given-names>C</given-names></name><name><surname>Dasta</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit</article-title><source>Crit Care Med</source><year>2013</year><volume>41</volume><fpage>263</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3182783b72</pub-id><pub-id pub-id-type="pmid">23269131</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantz</surname><given-names>J</given-names></name><name><surname>Josserand</surname><given-names>J</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name></person-group><article-title>Dexmedetomidine: new insights</article-title><source>Eur J Anaesthesiol</source><year>2011</year><volume>28</volume><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1097/EJA.0b013e32833e266d</pub-id><pub-id pub-id-type="pmid">20881501</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arain</surname><given-names>SR</given-names></name><name><surname>Ruehlow</surname><given-names>RM</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Ebert</surname><given-names>TJ</given-names></name></person-group><article-title>The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery</article-title><source>Anesth Analg</source><year>2004</year><volume>98</volume><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000093225.39866.75</pub-id><pub-id pub-id-type="pmid">14693611</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>KP</given-names></name></person-group><article-title>Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations</article-title><source>Br J Anaesth</source><year>2015</year><volume>11</volume><fpage>171</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1093/bja/aev226</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peden</surname><given-names>CJ</given-names></name><name><surname>Cloote</surname><given-names>AH</given-names></name><name><surname>Stratford</surname><given-names>N</given-names></name><name><surname>Prys-Roberts</surname><given-names>C</given-names></name></person-group><article-title>The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil</article-title><source>Anaesthesia</source><year>2001</year><volume>56</volume><fpage>408</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2044.2001.01553.x</pub-id><pub-id pub-id-type="pmid">11350323</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingersoll-Weng</surname><given-names>E</given-names></name><name><surname>Manecke</surname><given-names>GR</given-names><suffix>Jr</suffix></name><name><surname>Thistlethwaite</surname><given-names>PA</given-names></name></person-group><article-title>Dexmedetomidine and cardiac arrest</article-title><source>Anesthesiology</source><year>2004</year><volume>100</volume><fpage>738</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1097/00000542-200403000-00040</pub-id><pub-id pub-id-type="pmid">15108994</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayer</surname><given-names>P</given-names></name><name><surname>Desmeules</surname><given-names>J</given-names></name><name><surname>Collart</surname><given-names>L</given-names></name></person-group><article-title>Pharmacology of tramadol</article-title><source>Drugs</source><year>1997</year><volume>53</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.2165/00003495-199700532-00006</pub-id><pub-id pub-id-type="pmid">9190321</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>YC</given-names></name><name><surname>Lin</surname><given-names>SM</given-names></name><name><surname>Hsieh</surname><given-names>YC</given-names></name></person-group><article-title>Intraoperative administration of tramadol for postoperative nurse-controlled analgesia resulted in earlier awakening and less sedation than morphine in children after cardiac surgery</article-title><source>Anesth Analg</source><year>2006</year><volume>102</volume><fpage>1668</fpage><lpage>1673</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000219587.02263.A0</pub-id><pub-id pub-id-type="pmid">16717306</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>T</given-names></name><name><surname>Steel</surname><given-names>E</given-names></name><name><surname>Johnston</surname><given-names>G</given-names></name><name><surname>Veitch</surname><given-names>DY</given-names></name></person-group><article-title>Tramadol for pain relief in children undergoing tonsillectomy: a comparison with morphine</article-title><source>Paediatr Anaesth</source><year>2003</year><volume>13</volume><fpage>249</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1046/j.1460-9592.2003.00983.x</pub-id><pub-id pub-id-type="pmid">12641688</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berg</surname><given-names>AA</given-names></name><name><surname>Montoya-Pelaez</surname><given-names>LF</given-names></name><name><surname>Halliday</surname><given-names>EM</given-names></name><name><surname>Hassan</surname><given-names>I</given-names></name><name><surname>Baloch</surname><given-names>MS</given-names></name></person-group><article-title>Analgesia for adenotonsillectomy in children and young adults: a comparison of tramadol, pethidine and nalbuphine</article-title><source>Eur J Anaesthesiol</source><year>1999</year><volume>16</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2346.1999.00451.x</pub-id><pub-id pub-id-type="pmid">10225169</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnabel</surname><given-names>A</given-names></name><name><surname>Reichl</surname><given-names>SU</given-names></name><name><surname>Meyer-Frie&#x000df;em</surname><given-names>C</given-names></name><name><surname>Zahn</surname><given-names>PK</given-names></name><name><surname>Pogatzki-Zahn</surname><given-names>E</given-names></name></person-group><article-title>Tramadol for postoperative pain treatment in children</article-title><source>Cochrane Database Syst Rev</source><year>2015</year><volume>18</volume><fpage>CD009574</fpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannallah</surname><given-names>RS</given-names></name><name><surname>Broadman</surname><given-names>LM</given-names></name><name><surname>Belman</surname><given-names>AB</given-names></name><name><surname>Abramowitz</surname><given-names>MD</given-names></name><name><surname>Epstein</surname><given-names>BS</given-names></name></person-group><article-title>Comparison of caudal and illeoinguinal/iliohypogastric nerve blocks for control of post-orchiopexy pain in pediatric ambulatory surgery</article-title><source>Anesthesiology</source><year>1987</year><volume>66</volume><fpage>832</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1097/00000542-198706000-00023</pub-id><pub-id pub-id-type="pmid">2884900</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikich</surname><given-names>N</given-names></name><name><surname>Lerman</surname><given-names>J</given-names></name></person-group><article-title>Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale</article-title><source>Anesthesiology</source><year>2004</year><volume>100</volume><fpage>1138</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1097/00000542-200405000-00015</pub-id><pub-id pub-id-type="pmid">15114210</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsay</surname><given-names>MA</given-names></name><name><surname>Savage</surname><given-names>TM</given-names></name><name><surname>Simson</surname><given-names>BR</given-names></name></person-group><article-title>Controlled sedation with alphaxalone-alphadolone</article-title><source>Br Med J</source><year>1974</year><volume>2</volume><fpage>656</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1136/bmj.2.5920.656</pub-id><pub-id pub-id-type="pmid">4835444</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnock</surname><given-names>FF</given-names></name><name><surname>Lander</surname><given-names>J</given-names></name></person-group><article-title>Pain progression, intensity and outcomes following tonsillectomy</article-title><source>Pain</source><year>1998</year><volume>75</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(97)00202-9</pub-id><pub-id pub-id-type="pmid">9539672</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belleville</surname><given-names>JP</given-names></name><name><surname>Ward</surname><given-names>DS</given-names></name><name><surname>Bloor</surname><given-names>BC</given-names></name><name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>1125</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1097/00000542-199212000-00013</pub-id><pub-id pub-id-type="pmid">1361310</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petroz</surname><given-names>GC</given-names></name><name><surname>Sikich</surname><given-names>N</given-names></name><name><surname>James</surname><given-names>M</given-names></name><name><surname>van Dyk</surname><given-names>H</given-names></name><name><surname>Shafer</surname><given-names>SL</given-names></name><name><surname>Schily</surname><given-names>M</given-names></name><etal/></person-group><article-title>A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children</article-title><source>Anesthesiology</source><year>2006</year><volume>105</volume><fpage>1098</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1097/00000542-200612000-00009</pub-id><pub-id pub-id-type="pmid">17122572</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>LE</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Franks</surname><given-names>NP</given-names></name><name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>The alpha 2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects</article-title><source>Anesthesiology</source><year>2003</year><volume>98</volume><fpage>428</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1097/00000542-200302000-00024</pub-id><pub-id pub-id-type="pmid">12552203</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhana</surname><given-names>N</given-names></name><name><surname>Goa</surname><given-names>KL</given-names></name><name><surname>Mcclellan</surname><given-names>KJ</given-names></name></person-group><article-title>Dexmedetomidine</article-title><source>Drugs</source><year>2000</year><volume>59</volume><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.2165/00003495-200059020-00012</pub-id><pub-id pub-id-type="pmid">10730549</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Perry</surname><given-names>CM</given-names></name></person-group><article-title>Tramadol: a review of its use in perioperative pain</article-title><source>Drugs</source><year>2000</year><volume>60</volume><fpage>139</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.2165/00003495-200060010-00008</pub-id><pub-id pub-id-type="pmid">10929933</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umuro&#x0011f;lu</surname><given-names>T</given-names></name><name><surname>Eti</surname><given-names>Z</given-names></name><name><surname>Cift&#x000e7;i</surname><given-names>H</given-names></name><name><surname>Yilmaz G&#x000f6;&#x0011f;&#x000fc;&#x0015f;</surname><given-names>F</given-names></name></person-group><article-title>Analgesia for adenotonsillectomy in children: a comparison of morphine, ketamine and tramadol</article-title><source>Paediatr Anaesth</source><year>2004</year><volume>14</volume><fpage>568</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9592.2004.01223.x</pub-id><pub-id pub-id-type="pmid">15200654</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzuillo</surname><given-names>P</given-names></name><name><surname>Calligaris</surname><given-names>L</given-names></name><name><surname>Barbi</surname><given-names>E</given-names></name></person-group><article-title>Tramadol can selectively manage moderate pain in children following European advice limiting codeine use</article-title><source>Acta Paediatr</source><year>2014</year><volume>103</volume><fpage>1110</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1111/apa.12738</pub-id><pub-id pub-id-type="pmid">25041277</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radbruch</surname><given-names>L</given-names></name><name><surname>Grond</surname><given-names>S</given-names></name><name><surname>Lehmann</surname><given-names>KA</given-names></name></person-group><article-title>A risk-benefit assessment of tramadol in the management of pain</article-title><source>Drug Saf</source><year>1996</year><volume>15</volume><fpage>8</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.2165/00002018-199615010-00002</pub-id><pub-id pub-id-type="pmid">8862961</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozkurt</surname><given-names>P</given-names></name></person-group><article-title>Use of tramadol in children</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><fpage>1041</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9592.2005.01738.x</pub-id><pub-id pub-id-type="pmid">16324021</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestieau</surname><given-names>SR</given-names></name><name><surname>Quezado</surname><given-names>ZM</given-names></name><name><surname>Johnson</surname><given-names>YJ</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Cheng</surname><given-names>YI</given-names></name><name><surname>Mccarter</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>High-dose dexmedetomidine increases the opioid-free interval and decreases opioid requirement after tonsillectomy in children</article-title><source>Can J Anaesth</source><year>2011</year><volume>58</volume><fpage>540</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1007/s12630-011-9493-7</pub-id><pub-id pub-id-type="pmid">21461792</pub-id></element-citation></ref></ref-list></back></article>